2
H index
1
i10 index
28
Citations
Bonny Parkinson : Citation Profile
Macquarie University | RESEARCH PRODUCTION: 14 Articles 2 Papers RESEARCH ACTIVITY:
MORE DETAILS IN: ABOUT THIS REPORT:
|
11 years (2011 - 2022). Relations with other researchers
Works with: Authors registered in RePEc who have co-authored more than one work in the last five years with Bonny Parkinson. | Is cited by:
| Cites to:
|
Main data
Where Bonny Parkinson has published?
| Journals with more than one article published | # docs |
|---|---|
| PharmacoEconomics | 5 |
| Applied Health Economics and Health Policy | 4 |
| The European Journal of Health Economics | 2 |
| Working Papers Series with more than one paper published | # docs |
|---|---|
| Working Papers / CHERE, University of Technology, Sydney | 2 |
Recent works citing Bonny Parkinson (2025 and 2024)
| Year | Title of citing document |
|---|---|
| 2024 | Mapping from SIBDQ to EQ-5D-5L for patients with inflammatory bowel disease. (2024). Stargardt, Tom ; Bokemeyer, Bernd ; Steiner, Isa Maria. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:25:y:2024:i:3:d:10.1007_s10198-023-01603-9. Full description at Econpapers || Download paper |
Works by Bonny Parkinson:
| Year | Title | Type | Cited |
|---|---|---|---|
| 2011 | Considering consumer choice in the economic evaluation of mandatory health programmes: A review In: Health Policy. [Full Text][Citation analysis] | article | 1 |
| 2012 | Measuring the loss of consumer choice in mandatory health programs using Discrete Choice Experiments. CHERE Working Paper 2012/04 In: Working Papers. [Citation analysis] | paper | 0 |
| 2013 | Pharmaceutical policy in Australia. CHERE Working Paper 2013/01 In: Working Papers. [Full Text][Citation analysis] | paper | 0 |
| 2011 | Integrating Health Economics Into the Product Development Cycle In: Medical Decision Making. [Full Text][Citation analysis] | article | 5 |
| 2013 | Measuring the Loss of Consumer Choice in Mandatory Health Programmes Using Discrete Choice Experiments In: Applied Health Economics and Health Policy. [Full Text][Citation analysis] | article | 2 |
| 2018 | The Real-World Cost-Effectiveness of Coronary Artery Bypass Surgery Versus Stenting in High-Risk Patients: Propensity Score-Matched Analysis of a Single-Centre Experience In: Applied Health Economics and Health Policy. [Full Text][Citation analysis] | article | 0 |
| 2019 | Economic Evaluations of Childhood Hearing Loss Screening Programmes: A Systematic Review and Critique In: Applied Health Economics and Health Policy. [Full Text][Citation analysis] | article | 0 |
| 2019 | Correction to: Economic Evaluations of Childhood Hearing Loss Screening Programmes: A Systematic Review and Critique In: Applied Health Economics and Health Policy. [Full Text][Citation analysis] | article | 0 |
| 2014 | Economic evaluations of trastuzumab in HER2-positive metastatic breast cancer: a systematic review and critique In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 2 |
| 2022 | The cost-effectiveness of unilateral cochlear implants in UK adults In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 0 |
| 2015 | Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review In: PharmacoEconomics. [Full Text][Citation analysis] | article | 15 |
| 2016 | Real-World Evidence: A Comparison of the Australian Herceptin Program and Clinical Trials of Trastuzumab for HER2-Positive Metastatic Breast Cancer In: PharmacoEconomics. [Full Text][Citation analysis] | article | 1 |
| 2016 | Authors’ Reply to Palozzo and Messori: ‘‘Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review’’ In: PharmacoEconomics. [Full Text][Citation analysis] | article | 0 |
| 2019 | Is Reclassification of the Oral Contraceptive Pill from Prescription to Pharmacist-Only Cost Effective? Application of an Economic Evaluation Approach to Regulatory Decisions In: PharmacoEconomics. [Full Text][Citation analysis] | article | 1 |
| 2022 | Cost-Effectiveness Analysis of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography (PET/CT) for the Primary Staging of Prostate Cancer in Australia In: PharmacoEconomics. [Full Text][Citation analysis] | article | 0 |
| 2022 | An examination of machine learning to map non‐preference based patient reported outcome measures to health state utility values In: Health Economics. [Full Text][Citation analysis] | article | 1 |
CitEc is a RePEc service, providing citation data for Economics since 2001. Last updated April, 14 2025. Contact: CitEc Team